2487 related articles for article (PubMed ID: 8093465)
41. Progress report of a phase II and a phase III trial with etanidazole (SR-2508): a multicentre European study.
Chassagne D; Sancho-Garnier H; Charreau I; Eschwege F; Malaise EP
Radiother Oncol; 1991; 20 Suppl 1():121-7. PubMed ID: 1826960
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of the in vivo radiosensitizing activity of etanidazole using tumor-bearing chick embryo.
Abe C; Uto Y; Nakae T; Shinmoto Y; Sano K; Nakata H; Teraoka M; Endo Y; Maezawa H; Masunaga S; Nakata E; Hori H
J Radiat Res; 2011; 52(2):208-14. PubMed ID: 21436611
[TBL] [Abstract][Full Text] [Related]
43. Cytotoxic effect of RB 6145 in human tumour cell lines: dependence on hypoxia, extra- and intracellular pH and drug uptake.
Skarsgard LD; Acheson DK; Vinczan A; Wouters BG; Heinrichs BE; Loblaw DA; Minchinton AI; Chaplin DJ
Br J Cancer; 1995 Dec; 72(6):1479-86. PubMed ID: 8519663
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetic monitoring and dose modification of etanidazole in the RTOG 85-27 phase III head and neck trial.
Riese NE; Buswell L; Noll L; Pajak TF; Stetz J; Lee DJ; Coleman CN
Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):855-8. PubMed ID: 9369134
[TBL] [Abstract][Full Text] [Related]
45. The multi-dose clinical tolerance and pharmacokinetics of the combined radiosensitizers, Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole).
Newman HF; Ward R; Workman P; Bleehen NM
Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1073-83. PubMed ID: 2972667
[TBL] [Abstract][Full Text] [Related]
46. Combined cytokinesis-block micronucleus and chromosomal aberration assay for the evaluation of radiosensitizers at low radiation doses.
Oya N; Shibamoto Y; Shibata T; Sasai K; Sugiyama T; Abe M
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1153-9. PubMed ID: 7961025
[TBL] [Abstract][Full Text] [Related]
47. Sensitization of Chinese hamster ovary cells to melphalan by etanidazole under intermittent hypoxia.
Bump EA; Coleman CN; Cerce BA; McGinnis DJ
Int J Radiat Oncol Biol Phys; 1992; 22(4):731-5. PubMed ID: 1531977
[TBL] [Abstract][Full Text] [Related]
48. Radiosensitizing activity and pharmacokinetics of multiple dose administered KU-2285 in peripheral nerve tissue in mice.
Iwai H; Matsuno E; Sasai K; Shibamoto Y; Abe M
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):591-4. PubMed ID: 8005821
[TBL] [Abstract][Full Text] [Related]
49. SR-2508 plus buthionine sulfoximine or SR-2508 alone: effects on the radiation response and the glutathione content of a human tumor xenograft.
Lespinasse F; Biscay P; Malaise EP; Guichard M
Radiat Res; 1987 Apr; 110(1):149-54. PubMed ID: 2951766
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles.
Koch CJ; Hahn SM; Rockwell K; Covey JM; McKenna WG; Evans SM
Cancer Chemother Pharmacol; 2001 Sep; 48(3):177-87. PubMed ID: 11592338
[TBL] [Abstract][Full Text] [Related]
51. PEG modulated release of etanidazole from implantable PLGA/PDLA discs.
Wang F; Lee T; Wang CH
Biomaterials; 2002 Sep; 23(17):3555-66. PubMed ID: 12109679
[TBL] [Abstract][Full Text] [Related]
52. Logistics in designing clinical trials for etanidazole (SR 2508): an RTOG experience.
Lee DJ; Phillips TL; Coleman CN; Cosmatos D; Davis LW; Wasserman TH; Marcial VA; Rubin P
Int J Radiat Oncol Biol Phys; 1992; 22(3):569-71. PubMed ID: 1531215
[TBL] [Abstract][Full Text] [Related]
53. Transient perfusion and radiosensitizing effect after nicotinamide, carbogen, and perflubron emulsion administration.
Thomas CD; Stern S; Chaplin DJ; Guichard M
Radiother Oncol; 1996 Jun; 39(3):235-41. PubMed ID: 8783400
[TBL] [Abstract][Full Text] [Related]
54. The radiosensitizing effects of hypoxic cell sensitizer on SCCVII tumors in mice evaluated by highly accurate colony formation assay assisted by microcomputer.
Ono K; Akuta K; Masunaga S; Kinashi Y; Suzuki M
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Dec; 56(14):1066-70. PubMed ID: 9014470
[No Abstract] [Full Text] [Related]
55. Interactions of hyperthermia with hypoxic cell sensitisers.
Bleehen NM; Walton MI; Workman P
Recent Results Cancer Res; 1988; 109():136-48. PubMed ID: 2972029
[No Abstract] [Full Text] [Related]
56. Gradient high-performance liquid chromatographic method for simultaneous assay of the radiosensitizers etanidazole (SR 2508) and pimonidazole (Ro 03-8799) in biological materials.
Ward R; Workman P
J Chromatogr; 1987 Sep; 420(1):223-7. PubMed ID: 2959677
[No Abstract] [Full Text] [Related]
57. Antagonism between radiosensitizing agents.
Berenbaum MC
Br J Radiol; 1988 Oct; 61(730):975-7. PubMed ID: 2973363
[No Abstract] [Full Text] [Related]
58. Selective uptake of para-boronophenylalanine increases in amelanotic melanoma cells transfected by the tyrosinase gene.
Hiratsuka J; Kondoh H; Tsuboi T; Yoshino K; Imajo Y; Mishima Y
Melanoma Res; 2000 Jun; 10(3):297-302. PubMed ID: 10890385
[TBL] [Abstract][Full Text] [Related]
59. [In vitro oxygen-dependent survival of 2 human cell lines after radiation combined with tirapazamine (SR-4233) and cisplatin].
Lartigau E; Stern S; Guichard M
Cancer Radiother; 2000; 4(3):217-22. PubMed ID: 10897765
[TBL] [Abstract][Full Text] [Related]
60. Nicotinamide and carbogen: relationship between pO2 and radiosensitivity in three tumour lines.
Martin LM; Thomas CD; Guichard M
Int J Radiat Biol; 1994 Mar; 65(3):379-86. PubMed ID: 7908317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
